In a recent study, Zeng demonstrated that FOXO1, a gene significantly associated with PDCD1, downregulated copper homeostasis is a novel indicator of breast cancer prognosis and immune response (Zeng et al., 2022). This evidence concerns the gene FOXO1 and breast cancer.